You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

locally advanced NSCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • +2 more
  • standard Radiotherapy
  • +3 more
  • (no location specified)
Oct 20, 2023

NSCLC, NSCLC Trial in Bronx (PembroRT, ChemoRT)

Active, not recruiting
  • Non-small Cell Lung Cancer, NSCLC
  • Bronx, New York
    Montefiore Medical Center
Dec 6, 2022

Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • CTV omitted or delineated
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 1, 2023

Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • carboplatin chemotherapy
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Nov 3, 2023

NSCLC, Consolidation Immunotherapy, Radiotherapy or Sequential Chemoradiation Trial in Beijing (Tislelizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Beijing, China
    Peking University Cancer Hospital and Institute
Mar 4, 2023

NSCLC Stage III, Radiotherapy Side Effect, Frailty Trial (Photon, Proton)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • +2 more
  • Photon
  • Proton
  • (no location specified)
Sep 20, 2022

Locally Advanced NSCLC, Chemoradiotherapy, Cavitation Lung Trial (Upfront resection)

Not yet recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • +5 more
  • Upfront resection
  • (no location specified)
Nov 9, 2022

Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)

Active, not recruiting
  • Lung Cancer, Non-small Cell
  • hypofractionated radiation therapy
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Mar 13, 2023

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • HS-10241+ Almonertinib
  • Pemetrexed + Cisplatin /Carboplatin
  • (no location specified)
Oct 29, 2023

Lung Cancer, Stage III Lung Cancer, Unresectable Lung Carcinoma Trial in Barcelona (procedure, diagnostic test, drug)

Recruiting
  • Lung Cancer
  • +2 more
  • Sample collection
  • +3 more
  • Barcelona, Spain
    Parc de Salut Mar - Hospital del Mar
Dec 8, 2022

NSCLC Trial (Sutetinib Maleate Capsule)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Sutetinib Maleate Capsule
  • (no location specified)
Aug 18, 2023

NSCLC (NSCLC) Trial in Jinan (WX-0593 Tablets, chemo, Thoracic Radiation Therapy(TRT))

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • WX-0593 Tablets
  • +2 more
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Apr 24, 2022

A Multi-center, Non-interventional, Prospective Study of

Recruiting
  • NSCLC, Non-small-cell Lung Carcinoma
    • Arkhangelsk, Russian Federation
    • +14 more
    Aug 9, 2022

    Unresectable NSCLC (NSCLC) and Urothelial Cancer Trial in India (Durvalumab)

    Recruiting
    • Unresectable Non-small Cell Lung Cancer (NSCLC) and Urothelial Cancer
    • Bangalore, India
    • +10 more
    Aug 24, 2022

    Pulmonary Tumor, Advanced Cancer, Locally Advanced Cancer Trial in Shanghai (Surgery)

    Recruiting
    • Pulmonary Neoplasm
    • +2 more
    • Surgery
    • Shanghai, Shanghai, China
      Ruijin hospital, Shanghai JiaoTong University School of Medicine
    Dec 15, 2022

    Metastatic or Locally Advanced NSCLC Trial in Ramat Gan (Durvalumab, Tremelimumab, Low dose irradiation)

    Recruiting
    • Metastatic or Locally Advanced NSCLC
    • Ramat Gan, Israel
      Sheba Medical Centre
    Jan 9, 2022

    NSCLC Trial in Shanghai (SY-5007)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Sep 4, 2023

    Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Guanzhou, China
      SunYat-senU
    May 5, 2023

    NSCLC Trial in China (BBP-398, osimertinib)

    Recruiting
    • NSCLC
    • Beijing, Beijing, China
    • +4 more
    Sep 4, 2023

    NSCLC Trial in Winter Haven (Poziotinib, Docetaxel)

    Suspended
    • NSCLC
    • Winter Haven, Florida
      Bond Clinic, P.A.
    Jan 27, 2023

    Lung Cancer Trial (Savolitinib, Durvalumab)

    Recruiting
    • Lung Cancer
    • Beijing, China
    • +2 more
    Jan 11, 2023

    Locally Advanced or Metastatic NSCLC Trial in Ohio City (PBF-1129)

    Active, not recruiting
    • Locally Advanced or Metastatic NSCLC
    • Ohio City, Ohio
      Division of medical Oncology A450B Starling Loving Hall
    Jan 24, 2023

    Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • (no location specified)
    May 8, 2023